Biopharmaceutical stocks listed in Hong Kong experienced a sharp decline in the afternoon session, with notable losses. Top Alliance Biosciences and Ascletis Pharma saw declines exceeding 7%, while InnoCare Pharma fell by more than 4%. Additionally, WuXi XDC, Tigermed, and Akeso BioPharma all recorded drops of over 3%.
